DNA is found primarily in the cell nucleus, where it exists in a linear form, in protein complexes. To study this nuclear DNA, cells must be broken open, and the DNA purified. However, DNA also circulates in the bloodstream outside of cells, known as cell-free DNA (cfDNA). This cfDNA can be easily collected through plasma separation without the need for cell lysis.
Cell-free DNA originates from apoptotic (programmed cell death) processes occurring throughout the body. During apoptosis, genomic DNA is fragmented and released into the bloodstream. Various cell types, including fat cells (adipocytes), placental cells, tumor cells, and transplanted cells, contribute to cfDNA when they undergo apoptosis. Although “foreign” cfDNA makes up a small fraction of the total cfDNA in the blood, it can be analyzed to detect placental aneuploidy, cancer-specific variants, and conditions like graft-versus-host disease (GvHD).
Real-time PCR
This technique uses allele-specific probes for targeted detection of pathogenic variants, particularly those on the Y chromosome. It can also detect duplications or deletions through relative quantification.
Droplet digital PCR (ddPCR)
ddPCR involves massive parallel partitioning a PCR mixture into thousands of tiny oil droplets, effectively diluting the starting material. This method offers high sensitivity and enables absolute quantification of cfDNA. It can distinguish between maternal and placental cfDNA and is used to detect point mutations, copy number variations (CNVs), loss of heterozygosity, and aneuploidy.
Shotgun sequencing
Shotgun sequencing, like ddPCR, can detect point mutations, CNVs, loss of heterozygosity, and aneuploidy in cfDNA. It also allows for whole-genome sequencing of the placental genome, making it a powerful tool for comprehensive analysis.
Mass spectrometry
MALDI-TOF MS can be used to sequence point mutations in cfDNA. In this process, an oligonucleotide binds just before the site of the point mutation and is extended by a single nucleotide (single nucleotide sequencing). Differences in mass allow for differentiation between homozygous and heterozygous base pair positions.
WAYS TO PARTNER WITH US
TarCET IVD Kits
CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form
Technology Transfer
Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing
Contact Us
Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.
BLOG ARTICLES
Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f…
Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced …
Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso…
Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co…
The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study…
Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a…
Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area…
February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…
Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…
Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…
